Innovating Works

VN

Desconocido
BIOREMIA: BIOfilm REsistant Materials for hard tissue Implant Applications ASHLAND SPECIALTIES IRELAND LIMITED participó en un H2020: H2020-MSCA-ITN-2019 Implant-associated infections, commonly caused by biofilm-forming bacteria, are highly problematic for the patient, the healthcare system, a...
2019-09-04 - 2024-06-30 | Financiado
3D NEONET: Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics ASHLAND SPECIALTIES IRELAND LIMITED participó en un H2020: H2020-MSCA-RISE-2016 Severe ocular disorders are affecting the lives of more than 100Mill people world-wide and at least 25% of the population above 70 years of...
2016-11-08 - 2022-06-30 | Financiado
MOZART: MesopOrous matrices for localiZed pH triggered releAse of theRapeuTic ions and drugs ASHLAND SPECIALTIES IRELAND LIMITED participó en un H2020: H2020-NMP-2014-2015 The concept behind MOZART is to develop a library of inorganic nanomatrices to be used as smart platforms for effective, non-invasive and hi...
2015-09-21 - 2019-10-31 | Financiado
MATRIXASSAY: Novel Cell Migration Assay Based on Microtissue Technology and Tissue Specific Matrices ASHLAND SPECIALTIES IRELAND LIMITED participó en un H2020: H2020-MSCA-RISE-2014 Cell migration assays are commonly used to study wound healing, cancer cell invasion, and tissue development. Problems associated with the g...
2015-04-23 - 2019-05-31 | Financiado
HyMedPoly: Drug Free Antibacterial Hybrid Biopolymers for Medical Applications ASHLAND SPECIALTIES IRELAND LIMITED participó en un H2020: H2020-MSCA-ITN-2014 There is a general consensus that biomedical polymers of natural and synthetic origin should and will play a very important role in the deve...
2014-12-05 - 2018-12-31 | Financiado
GREEN NANO-MESH: Targeting Hernia Operation Using Sustainable Resources and Green Nanotechnologies. An Integrated Pan... ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: Hernia operations are among the most common surgical procedures performed today with over 20 million cases annually worldwide. Hernia incide...
Financiado
REBIOSTENT: Reinforced Bioresorbable Biomaterials for Therapeutic Drug Eluting Stents ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: Active therapeutic biodegradable and biocompatible materials are highly in demand. These are required for the production of medicinal produc...
Financiado
NeuroGraft: Development of Functionalised Cell Seeded Bioartificial Organ for Transplantation in Nerve Repair ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: Injuries and degenerative diseases of the central nervous system constitute a bottleneck in medical and surgical practice for which no thera...
Financiado
NEURIMP: Novel combination of biopolymers and manufacturing technologies for production of a peripheral nerve... ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: Peripheral nerves are basic communication structures guiding motor and sensitive information from CNS to effector or receptor units. Severe...
Financiado
TENDON REGENERATION: Targeting Functional Tendon Regeneration Using a Loaded Biomimetic Scaffold. An Integrated Pan Europ... ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: This industry-academia proposal addresses the development of technology which will enable understanding of regeneration of injured or degene...
Financiado
EPICSTENT: Antibody functionalised cardiovascular stents for improved biocompatibility and reduced restenosis ASHLAND SPECIALTIES IRELAND LIMITED participó en un FP7: An industry-academia collaboration is proposed wherein two industry and three academic partners will establish a lasting, inter-national par...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.